From new pricing and reimbursement rules to R&D incentives, discover how China’s 2025 Two Sessions policy reforms are creating opportunities in healthcare.
Are there still blue oceans and growth opportunities for GLP-1? In this blog, we analyse the market competition and how firms can seize a share of the pie.
Top execs share key insights on international expansion and business development strategies in Ergomed and JC Consulting's inaugural biotech conference.